MedTech Dive June 12, 2024
A median of 33% of study subjects were women, and the figure was significantly lower in cardiovascular trials.
Dive Brief:
- Women are underrepresented in studies of high-risk medical implants, according to a paper published in JAMA Internal Medicine Monday.
- The analysis of trials published from January 2016 to May 2022 found a median of 33% of study subjects were women. Women made up a significantly smaller portion of cardiovascular disease trials, accounting for 27% of the people enrolled in stent studies.
- Improved awareness and initiatives are essential to ensure adequate enrollment of women, wrote the authors of the paper.
Dive Insight:
Women differ from men in body size, hormonal variations and other ways that can affect the...
Today's Sponsors
Today's Sponsor